Alejandra Gallardo-Godoy
Alejandra Gallardo-Godoy
Research Scientist
Verified email at
Cited by
Cited by
2-Aminothiazoles as therapeutic leads for prion diseases
A Gallardo-Godoy, J Gever, KL Fife, BM Silber, SB Prusiner, AR Renslo
Journal of medicinal chemistry 54 (4), 1010-1021, 2011
Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis
A Gallardo-Godoy
US Patent 8,802,844, 2014
1-Aminomethylbenzocycloalkanes:  Conformationally Restricted Hallucinogenic Phenethylamine Analogues as Functionally Selective 5-HT2A Receptor Agonists
TH McLean, JC Parrish, MR Braden, D Marona-Lewicka, ...
Journal of medicinal chemistry 49 (19), 5794-5803, 2006
Sulfur-substituted α-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling
A Gallardo-Godoy, A Fierro, TH McLean, M Castillo, BK Cassels, ...
Journal of medicinal chemistry 48 (7), 2407-2419, 2005
Activity and predicted nephrotoxicity of synthetic antibiotics based on polymyxin B
A Gallardo-Godoy, C Muldoon, B Becker, AG Elliott, LH Lash, JX Huang, ...
Journal of medicinal chemistry 59 (3), 1068-1077, 2016
A High-Throughput Functional Screen Identifies Small Molecule Regulators of Temperature- and Mechano-Sensitive K2P Channels
SN Bagriantsev, KH Ang, A Gallardo-Godoy, KA Clark, MR Arkin, ...
ACS chemical biology 8 (8), 1841-1851, 2013
Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis
A Gallardo-Godoy
US Patent 9,399,648, 2016
Lead identification to clinical candidate selection: drugs for Chagas disease
RJ Neitz, S Chen, F Supek, V Yeh, D Kellar, J Gut, C Bryant, ...
Journal of biomolecular screening 20 (1), 101-111, 2015
Pharmacokinetics and metabolism of 2-aminothiazoles with antiprion activity in mice
BM Silber, S Rao, KL Fife, A Gallardo-Godoy, AR Renslo, DK Dalvie, ...
Pharmaceutical research 30 (4), 932-950, 2013
Structure, function, and biosynthetic origin of octapeptin antibiotics active against extensively drug-resistant Gram-negative bacteria
T Velkov, A Gallardo-Godoy, JD Swarbrick, MAT Blaskovich, AG Elliott, ...
Cell chemical biology 25 (4), 380-391. e5, 2018
Different 2-aminothiazole therapeutics produce distinct patterns of scrapie prion neuropathology in mouse brains
K Giles, DB Berry, C Condello, RC Hawley, A Gallardo-Godoy, C Bryant, ...
Journal of Pharmacology and Experimental Therapeutics 355 (1), 2-12, 2015
2-Aminothiazoles with improved pharmacotherapeutic properties for treatment of prion disease
Z Li, BM Silber, S Rao, J Gever, C Bryant, A Gallardo-Godoy, E Dolghih, ...
ChemMedChem 8 (5), 847, 2013
Probing the Steric Space at the Floor of the D1 Dopamine Receptor Orthosteric Binding Domain: 7α-, 7β-, 8α-, and 8β-Methyl Substituted Dihydrexidine Analogues
JP Cueva, A Gallardo-Godoy, JI Juncosa Jr, PA Vidi, MA Lill, VJ Watts, ...
Journal of medicinal chemistry 54 (15), 5508-5521, 2011
Antiprion compounds that reduce PrPSc levels in dividing and stationary-phase cells
BM Silber, JR Gever, Z Li, A Gallardo-Godoy, AR Renslo, K Widjaja, ...
Bioorganic & medicinal chemistry 21 (24), 7999-8012, 2013
Protein and Chemical Determinants of BL-1249 Action and Selectivity for K2P Channels
L Pope, C Arrigoni, H Lou, C Bryant, A Gallardo-Godoy, AR Renslo, ...
ACS chemical neuroscience 9 (12), 3153-3165, 2018
1-Methylpyridinium-4-(4-phenylmethanethiosulfonate) iodide, MTS-MPP+, a novel scanning cysteine accessibility method (SCAM) reagent for monoamine transporter studies
A Gallardo-Godoy, MI Torres-Altoro, KJ White, EL Barker, DE Nichols
Bioorganic & medicinal chemistry 15 (1), 305-311, 2007
Synthesis of octapeptin C4 and biological profiling against NDM-1 and polymyxin-resistant bacteria
B Becker, MS Butler, KA Hansford, A Gallardo-Godoy, AG Elliott, ...
Bioorganic & medicinal chemistry letters 27 (11), 2407-2409, 2017
Synthesis of 4-methyl-thio-phenyl-propylamine and the evaluation of its interaction with different amine oxidases
A Gallardo-Godoy, M Hernandez, E Sanz, M Unzeta
Bioorganic & medicinal chemistry 12 (1), 273-279, 2004
Structure-function studies of polymyxin B lipononapeptides
A Gallardo-Godoy, KA Hansford, C Muldoon, B Becker, AG Elliott, ...
Molecules 24 (3), 553, 2019
When is a medicine unwanted, how is it disposed, and how might safe disposal be promoted? Insights from the Australian population
E Bettington, J Spinks, F Kelly, A Gallardo-Godoy, S Nghiem, AJ Wheeler
Australian Health Review 42 (6), 709-717, 2018
The system can't perform the operation now. Try again later.
Articles 1–20